Search results
Author(s):
Josef Kautzner
,
Petr Peichl
Added:
3 years ago
Ventricular fibrillation (VF) is a complex arrhythmia that leads invariably to cardiac arrest. Its mechanisms remain largely unclear. Similar to atrial fibrillation, the mother rotor hypothesis is one plausible alternative.1,2 In larger animals, some authors reported that the dominant frequency of VF could be recorded at a junction of the left ventricular posterior wall and the septum.3-6 Others…
View more
ThermoCool® SmartTouch® Catheter
Author(s):
Tina Lin
,
Feifan Ouyang
,
Karl-Heinz Kuck
,
et al
Added:
3 years ago
Article
Author(s):
Tina Baykaner
,
Junaid AB Zaman
,
Paul J Wang
,
et al
Added:
3 years ago
Treatment of atrial fibrillation (AF) classically focuses on eliminating triggers near and from the pulmonary veins, which may initiate AF. However, the 1–2 year success rate of pulmonary vein isolation (PVI) remains 40–50% for persistent AF1,2 and 50–65% for paroxysmal AF,3–5 while supplementary linear lesions or extensive ablation at electrogram-targets have had disappointing results and may…
View more
Author(s):
Paulus Kirchhof
Added:
7 months ago
ESC 2023 — Prof Paulus Kirchhof (University Heart & Vascular Center Hamburg, DE) discusses the findings of the NOAH-AFNET 6 trial (NCT02618577).
NOAH-AFNET 6 (Atrial Fibrillation Network, Daiichi Sankyo Europe) was an investigator-initiated, prospective, randomised trial aiming to demonstrate that oral anticoagulation using the NOAC edoxaban is superior to current therapy in stroke prevention,…
View more
Author(s):
Justine Bhar-Amato
,
William Davies
,
Sharad Agarwal
Added:
3 years ago
Ventricular tachyarrhythmias (VAs) most commonly occur early in ischaemia, and patients presenting with an acute MI and ventricular arrhythmias are a group that has a significantly increased risk of mortality.1,2 Thrombolysis primary percutaneous coronary intervention (PCI) and use of beta-blockers, while resulting in the modification of the natural history of an infarct, have also reduced the…
View more
Author(s):
Tom Nelson
,
Pankaj Garg
,
Richard H Clayton
,
et al
Added:
3 years ago
Ventricular tachycardia (VT) and VF occur mainly in people with impaired cardiac function and/or ischaemic heart disease, and account for the majority of sudden cardiac deaths worldwide.1 Treatment with anti-arrhythmic drugs such as amiodarone may be at best neutral in terms of mortality and carries significant long-term risks.2,3 While ICDs significantly improve survival for patients with…
View more
Author(s):
José-Ángel Cabrera
,
Robert H Anderson
,
Andreu Porta-Sánchez
,
et al
Added:
2 years ago
Cecilia Low Wang
Author
Ting Ting Low
Research Area(s) / Expertise: Author
Prevention & Chronic Conditions
Inherited and Congenital Cardiac Conditions
Job title: Director, Women Heart Health Programme, Senior Consultant, Department of Cardiology, National University Heart Centre, Singapore
Author(s):
Marco Bergonti
Added:
11 months ago
EHRA 23 - Dr Marco Bergonti (Istituto Cardiocentro Ticino, CH) to discuss the key takeaways from the ANTWOORD II Trial.
In this study, 605 heart failure patients undergoing atrial fibrillation ablation were enrolled to receive an ANTWERP Score, which aimed to predict LVEF recovery. 70% of patients were categorised as 'responders', patients identified as those who could benefit the most from AF…
View more